Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuwei Pan

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
The EMBO Journal|March 5, 2020
Secreted stromal protein ISLR promotes intestinal regeneration by suppressing epithelial Hippo signalingJiuzhi Xu, Yang Tang, Xiaole Sheng, et al.
Nature Communications|February 6, 2025
ROS-induced cytosolic release of mitochondrial PGAM5 promotes colorectal cancer progression by interacting with MST3Shiyang Wang, Xi Wu, Wenxin Bi, et al.
Theranostics|October 24, 2022
Identifying the E2F3-MEX3A-KLF4 signaling axis that sustains cancer cells in undifferentiated and proliferative stateXu Yang, Guilin Li, Yuhua Tian, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 9, 2024
Stabilization of TGF-β Receptor 1 by a Receptor-Associated Adaptor Dictates Feedback Activation of the TGF-β Signaling Pathway to Maintain Liver Cancer Stemness and Drug ResistanceKewei Liu, Fanxuan Tian, Xu Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2023
Excessive nucleic acid R-loops induce mitochondria-dependent epithelial cell necroptosis and drive spontaneous intestinal inflammationXu Yang, Guilin Li, Pengbo Lou, et al.
Medcomm|October 30, 2024
Reduced intestinal-to-diffuse conversion and immunosuppressive responses underlie superiority of neoadjuvant immunochemotherapy in gastric adenocarcinomaLei Wang, Linghong Wan, Xu Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 4, 2024
Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II TrialLei Wang, Mengting Sun, Jinyang Li, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
The EMBO Journal|March 5, 2020
Secreted stromal protein ISLR promotes intestinal regeneration by suppressing epithelial Hippo signalingJiuzhi Xu, Yang Tang, Xiaole Sheng, et al.
Nature Communications|February 6, 2025
ROS-induced cytosolic release of mitochondrial PGAM5 promotes colorectal cancer progression by interacting with MST3Shiyang Wang, Xi Wu, Wenxin Bi, et al.
Theranostics|October 24, 2022
Identifying the E2F3-MEX3A-KLF4 signaling axis that sustains cancer cells in undifferentiated and proliferative stateXu Yang, Guilin Li, Yuhua Tian, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 9, 2024
Stabilization of TGF-β Receptor 1 by a Receptor-Associated Adaptor Dictates Feedback Activation of the TGF-β Signaling Pathway to Maintain Liver Cancer Stemness and Drug ResistanceKewei Liu, Fanxuan Tian, Xu Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2023
Excessive nucleic acid R-loops induce mitochondria-dependent epithelial cell necroptosis and drive spontaneous intestinal inflammationXu Yang, Guilin Li, Pengbo Lou, et al.
Medcomm|October 30, 2024
Reduced intestinal-to-diffuse conversion and immunosuppressive responses underlie superiority of neoadjuvant immunochemotherapy in gastric adenocarcinomaLei Wang, Linghong Wan, Xu Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 4, 2024
Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II TrialLei Wang, Mengting Sun, Jinyang Li, et al.
Pageof 10